• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

AgaMatrix lands $32m loan for split

October 6, 2017 By Sarah Faulkner

AgamatrixWith a $32 million loan in hand, AgaMatrix said this week it plans to reorganize the companies into two entities – AgaMatrix, Inc. and WaveForm Technologies.

The holding company raised $32 million from Prospect Capital Corp. and said it will use the funds to support sales and marketing, product development and clinical trial activities for its blood glucose monitoring products and closed-loop insulin delivery solutions.

“With the completion of the Prospect transaction, we’ve initiated the remaining steps to complete the reorganization of our company,” AgaMatrix Holdings president & CEO John Alberico said in prepared remarks.

“These next steps will enable each organization to focus on its strongest competencies and set an appropriate strategic direction. We are excited about the technology, products and services our two companies offer to the diabetes community and their caregivers.”

AgaMatrix is slated to focus on the company’s currently marketed blood glucose monitoring products, like its recently-launched Jazz Wireless 2 Bluetooth-enabled BGM product and its diabetes manager software app.

Meanwhile, WaveForm Technologies plans to focus on the development of a proprietary CGM platform, the company reported. The technology was bought last year from iSense CGM Inc. and Bayer Healthcare and features painless needle insertion and longer potential sensor life, the company touted.

Filed Under: Diabetes, Drug-Device Combinations, Featured, Funding Roundup, Patient Monitoring, Pharmaceuticals, Wall Street Beat Tagged With: agamatrix

IN CASE YOU MISSED IT

  • Abbott could pave new roads in diabetes management with dual sensor on the horizon
  • Tandem Diabetes Care pairs t:slim X2 pump with Abbott FreeStyle Libre 3 Plus in U.S.
  • Ypsomed, CamDiab to integrate Abbott dual glucose-ketone sensor into automated insulin delivery system
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump
  • Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS